The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues1
The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues1
复制标题
鼻内给药的霍乱毒素衍生 CTA1-DD 疫苗佐剂不会引起炎症或在神经组织中积聚1
作者：
A. Eriksson;K. Schön;N. Lycke
Although highly effective, the use of GM1-receptor binding holotoxins as nasal mucosal adjuvants has recently been cautioned due to the risk for their accumulation in the brain and other nervous tissues. Therefore we have explored the efficacy of the CTA1-DD adjuvant for its ability to enhance nasal immune responses in mice. We found that despite the lack of a mucosal binding element, the B cell-targeted CTA1-DD molecule was an equally strong adjuvant as cholera toxin (CT). The potency of CTA1-DD was not a result of endotoxin contamination because more than a 50-fold higher dose of LPS was needed to achieve a similar enhancement. Moreover, the adjuvant effect was TLR4-independent and absent in mutant CTA1-E112K-DD, lacking enzymatic activity. The CTA1-DD adjuvant augmented germinal center formations and T cell priming in the draining lymph nodes, and contrary to CT, promoted a balanced Th1/Th2 response with little effect on IgE Ab production. CTA1-DD did not induce inflammatory changes in the nasal mucosa, and most importantly did not bind to or accumulate in the nervous tissues of the olfactory bulb, whereas CT bound avidly to the nervous tissues. We believe that the nontoxic CTA1-DD adjuvant is an attractive solution to the current dilemma between efficacy and toxicity encountered in CT-holotoxin adjuvant or Escherichia coli heat-labile toxin-holotoxin adjuvant strategies and provides a safe and promising candidate to be included in future vaccines for intranasal administration.
登录
查看更多内容
阻断 CD28-B7 对实验性利什曼病中 Th1 或 Th2 效应细胞发育的不同影响。
DOI：
--
发表时间：
1994
期刊：
Journal of immunology (Baltimore, Md. : 1950)
影响因子：
--
作者：
Corry,DB;Reiner,SL;Linsley,PS;Locksley,RM
通讯作者：
Locksley,RM
当与蛋白质免疫原共同施用时，IL-1 是粘膜和全身免疫反应的有效佐剂。
DOI：
--
发表时间：
1999
期刊：
Journal of immunology (Baltimore, Md. : 1950)
影响因子：
--
作者：
Staats,HF;EnnisJr,FA
通讯作者：
EnnisJr,FA
高度纯化的霍乱毒素突变体 E112K 可引发对白喉毒素的保护性肺粘膜免疫。
影响因子：
5.5
作者：
Ohmura,M;Yamamoto,M;Kiyono,H;Fujihashi,K;Takeda,Y;McGhee,JR
通讯作者：
McGhee,JR
通过体内抗原呈递的直接可视化分析佐剂功能：内毒素促进淋巴组织 T 细胞区域中携带抗原的树突状细胞的积累。
DOI：
--
发表时间：
1999
期刊：
Journal of immunology (Baltimore, Md. : 1950)
影响因子：
--
作者：
ReiseSousa,C;Germain,RN
通讯作者：
Germain,RN